Monoclonal Antibodies Market by Application and Geography - Forecast and Analysis 2021-2025

  • Published: Mar 2021
  • Pages: 120
  • SKU: IRTNTR44342
Technavio

Purchase this report now and if we publish a new version within 90 days, we will send you a free copy.

Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The monoclonal antibodies market size has the potential to grow by USD 63.41 billion during 2021-2025, and the market’s growth momentum will accelerate at a CAGR of 8.20%. 

This report provides a detailed analysis of the market by application (oncology, autoimmune disorders, infectious diseases, and other applications), geography (North America, Europe, Asia, and ROW), and key vendors. 

Market Overview

Monoclonal-Antibodies-Market-Market-Size-2020-2025

Browse TOC and LoE with selected illustrations and example pages of Monoclonal Antibodies Market

 Request a FREE sample now!

Market Competitive Analysis

The report analyzes the market’s competitive landscape and offers information on several market vendors, including: 

 

  • AbbVie Inc.
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA

 

The monoclonal antibodies market is concentrated and the vendors are deploying growth strategies such as partnering with research organizations and hospitals for R&D and participating in various scientific conferences to compete in the market. Click here to uncover other successful business strategies deployed by the vendors. 

The market players also significantly leverage external market drivers such as the introduction of low-priced biosimilar monoclonal antibodies to achieve growth opportunities. However, factors such as the low safety profile of biologics will challenge the growth of the market participants. To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Download a free sample of the monoclonal antibodies market forecast report for insights on complete key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

This monoclonal antibodies market analysis report also provides detailed information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities. 

Monoclonal Antibodies Market: Key Drivers and Trends

  • The introduction of low-priced biosimilar monoclonal antibodies is one of the major factors that is driving the monoclonal antibodies market growth.
  • The low cost of biosimilars is due to the lesser number of clinical trials required compared to the original biologic drug.
  • This has encouraged various biosimilar manufacturers to adopt strategies to develop biosimilars for monoclonal antibodies.
  • Biosimilars of a few widely sold antibodies have already entered the market, while others are in the pipeline.
  • Manufacturers are also investing in single-use technology to keep production costs low. 
  • The growth in the number of companies venturing into the monoclonal antibodies space is one of the key monoclonal antibodies market trends that will positively impact market growth.
  • Several pharma companies are investing heavily in the development of monoclonal antibodies.
  • While large companies are focused on improving capacities and becoming major players in this growing market, several smaller companies are emerging with a good number of monoclonal antibodies.

 

Grab your Free Sample now to unlock further information on other key market drivers

Monoclonal Antibodies Market: Segmentation by Geography

Monoclonal-Antibodies-Market-Market-Share-by-Region-2020-2025

For more insights on the market share of various regions Request for a FREE sample now!

61% of the market’s growth will originate from North America during the forecast period. The US is a key market for monoclonal antibodies in North America. However, market growth in this region will be slower than the growth of the market in Asia.

The increased incidences of cancers and immunological disorders will facilitate the monoclonal antibodies market growth in North America over the forecast period. To garner further competitive intelligence and regional opportunities in store for vendors, view our sample report. 

Monoclonal Antibodies Market: Segmentation by Application

Monoclonal-Antibodies-Market-Market-Share-by-Application-2020-2025

Request for a FREE sample and Get more information on the market contribution of various segments

Some of the cancers for which monoclonal antibodies are widely used include acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), lymphomas, prostate cancer, breast cancer, cervical cancer, and ovarian cancers. The applications of monoclonal antibodies in the field of oncology are many, and due to the increased risks of cancer worldwide, the demand for monoclonal antibodies is increasing continuously. In addition to the increasing incidences of different types of cancers, the willingness of people to pay for highly-priced monoclonal antibodies for the treatment of cancers drives the growth of this segment. 

Fetch actionable market insights on post COVID-19 impact on each segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the monoclonal antibodies market size.

 

Event-Tickets-Market-Report

Request for a FREE sample

Monoclonal Antibodies Market: Key Highlights of the Report for 2021-2025

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive monoclonal antibodies market growth during the next five years
  • Precise estimation of the monoclonal antibodies market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the monoclonal antibodies industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of monoclonal antibodies market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
The monoclonal antibodies market growth will increase by $54.55 billion during 2019-2024.
The monoclonal antibodies market is expected to grow at a CAGR of 7.49% during 2019-2024.
Technavio has segmented the monoclonal antibodies market by application (Oncology, Autoimmune disorders, Infectious diseases, and Other applications) and geographic (North America, Europe, Asia, and ROW).
AbbVie Inc., AstraZeneca Plc, Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi are a few of the key vendors in the monoclonal antibodies market.
North America will register the highest growth rate of 54.28% among the other regions. Therefore, the monoclonal antibodies market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
The key factors driving the monoclonal antibodies market growth are:
  • Introduction of low-priced biosimilar monoclonal antibodies
  • Increasing cases of diseases like cancer and immunological disorders
The monoclonal antibodies market vendors should focus on grabbing business opportunities from the oncology segment as it accounted for the largest market share in the base year.
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase

Technavio's SUBSCRIPTION platform

Register for a free trial today and gain instant access to 17,000+ market research reports.

START YOUR FREE TRIAL

Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Report
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>